BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 29589297)

  • 1. Clinical Impact of p27
    Sengul Aycicek G; Aydogan BI; Sahin M; Cansız Ersoz C; Sak SD; Baskal N
    Endocr Pathol; 2018 Sep; 29(3):250-258. PubMed ID: 29589297
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Simultaneous expression analysis of vitamin D receptor, calcium-sensing receptor, cyclin D1, and PTH in symptomatic primary hyperparathyroidism in Asian Indians.
    Varshney S; Bhadada SK; Saikia UN; Sachdeva N; Behera A; Arya AK; Sharma S; Bhansali A; Mithal A; Rao SD
    Eur J Endocrinol; 2013 Jul; 169(1):109-16. PubMed ID: 23660642
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Possible Link Between Parathyroid Hormone Secretion and Local Regulation of GABA in Human Parathyroid Adenomas.
    Hong AR; Kim YA; Bae JH; Min HS; Kim JH; Shin CS; Kim SY; Kim SW
    J Clin Endocrinol Metab; 2016 Jun; 101(6):2594-601. PubMed ID: 27070188
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The role of calcium sensitive and vitamin D receptors in the pathogenesis of sporadic multiple parathyroid gland disease].
    Ilyicheva EA; Shurygina IA; Dremina NN; Bersenev GA; Grigoryev EG
    Probl Endokrinol (Mosk); 2023 Jun; 69(3):24-34. PubMed ID: 37448244
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CaSR expression in normal parathyroid and PHPT: new insights into pathogenesis from an autopsy-based study.
    Agarwal S; Kardam S; Chatterjee P; Kumar C; Boruah M; Sharma MC; Tabin M; Ramakrishnan L
    J Endocrinol Invest; 2022 Feb; 45(2):337-346. PubMed ID: 34302683
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decrease in vitamin D receptor and calcium-sensing receptor in highly proliferative parathyroid adenomas.
    Yano S; Sugimoto T; Tsukamoto T; Chihara K; Kobayashi A; Kitazawa S; Maeda S; Kitazawa R
    Eur J Endocrinol; 2003 Apr; 148(4):403-11. PubMed ID: 12656660
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduced vitamin D receptor expression in parathyroid adenomas: implications for pathogenesis.
    Sudhaker Rao D; Han ZH; Phillips ER; Palnitkar S; Parfitt AM
    Clin Endocrinol (Oxf); 2000 Sep; 53(3):373-81. PubMed ID: 10971456
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulator of G protein signaling 5 is highly expressed in parathyroid tumors and inhibits signaling by the calcium-sensing receptor.
    Koh J; Dar M; Untch BR; Dixit D; Shi Y; Yang Z; Adam MA; Dressman H; Wang X; Gesty-Palmer D; Marks JR; Spurney R; Druey KM; Olson JA
    Mol Endocrinol; 2011 May; 25(5):867-76. PubMed ID: 21393447
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ex Vivo Intact Tissue Analysis Reveals Alternative Calcium-sensing Behaviors in Parathyroid Adenomas.
    Koh J; Zhang R; Roman S; Duh QY; Gosnell J; Shen W; Suh I; Sosa JA
    J Clin Endocrinol Metab; 2021 Oct; 106(11):3168-3183. PubMed ID: 34272844
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutation analysis of MEN1, HRPT2, CASR, CDKN1B, and AIP genes in primary hyperparathyroidism patients with features of genetic predisposition.
    Vierimaa O; Villablanca A; Alimov A; Georgitsi M; Raitila A; Vahteristo P; Larsson C; Ruokonen A; Eloranta E; Ebeling TM; Ignatius J; Aaltonen LA; Leisti J; Salmela PI
    J Endocrinol Invest; 2009 Jun; 32(6):512-8. PubMed ID: 19474519
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Involvement of α-klotho, fibroblast growth factor-, vitamin-D- and calcium-sensing receptor in 53 patients with primary hyperparathyroidism.
    Latus J; Lehmann R; Roesel M; Fritz P; Braun N; Ulmer C; Steurer W; Biegger D; Ott G; Dippon J; Alscher MD; Kimmel M
    Endocrine; 2013 Aug; 44(1):255-63. PubMed ID: 23334987
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MEN1-related hyperparathyroidism: response to cinacalcet and its relationship with the calcium-sensing receptor gene variant Arg990Gly.
    Filopanti M; Verga U; Ermetici F; Olgiati L; Eller-Vainicher C; Corbetta S; Persani L; Beck-Peccoz P; Spada A
    Eur J Endocrinol; 2012 Aug; 167(2):157-64. PubMed ID: 22577108
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular pathogenesis of primary hyperparathyroidism.
    Cetani F; Pardi E; Borsari S; Marcocci C
    J Endocrinol Invest; 2011 Jul; 34(7 Suppl):35-9. PubMed ID: 21985978
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vitamin D status, seasonal variations, parathyroid adenoma weight and bone mineral density in primary hyperparathyroidism.
    Moosgaard B; Vestergaard P; Heickendorff L; Melsen F; Christiansen P; Mosekilde L
    Clin Endocrinol (Oxf); 2005 Nov; 63(5):506-13. PubMed ID: 16268801
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Single-cell functional analysis of parathyroid adenomas reveals distinct classes of calcium sensing behaviour in primary hyperparathyroidism.
    Koh J; Hogue JA; Wang Y; DiSalvo M; Allbritton NL; Shi Y; Olson JA; Sosa JA
    J Cell Mol Med; 2016 Feb; 20(2):351-9. PubMed ID: 26638194
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The calcium-sensing receptor and vitamin D receptor expression in tertiary hyperparathyroidism.
    Grzela T; Chudzinski W; Lasiecka Z; Niderla J; Wilczynski G; Gornicka B; Wasiutynski A; Durlik M; Boszczyk A; Brawura-Biskupski-Samaha R; Dziunycz P; Milewski L; Lazarczyk M; Lazarczyk M; Nawrot I
    Int J Mol Med; 2006 May; 17(5):779-83. PubMed ID: 16596260
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loss of p27 expression is associated with MEN1 gene mutations in sporadic parathyroid adenomas.
    Borsari S; Pardi E; Pellegata NS; Lee M; Saponaro F; Torregrossa L; Basolo F; Paltrinieri E; Zatelli MC; Materazzi G; Miccoli P; Marcocci C; Cetani F
    Endocrine; 2017 Feb; 55(2):386-397. PubMed ID: 27038812
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inactivating calcium-sensing receptor mutations in patients with primary hyperparathyroidism.
    Frank-Raue K; Leidig-Bruckner G; Haag C; Schulze E; Lorenz A; Schmitz-Winnenthal H; Raue F
    Clin Endocrinol (Oxf); 2011 Jul; 75(1):50-5. PubMed ID: 21521328
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduced Calcium Sensing Receptor (CaSR) Expression Is Epigenetically Deregulated in Parathyroid Adenomas.
    Singh P; Bhadada SK; Dahiya D; Arya AK; Saikia UN; Sachdeva N; Kaur J; Brandi ML; Rao SD
    J Clin Endocrinol Metab; 2020 Sep; 105(9):3015-24. PubMed ID: 32609827
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Primary and secondary hyperparathyroidism present different expressions of calcium-sensing receptor.
    Li X; Lu Y; Zhang L; Song A; Zhang H; Pang B; Liu J; Sun X; Ji H; Huang L; Yang M
    BMC Surg; 2023 Feb; 23(1):31. PubMed ID: 36755240
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.